Following the recent discontinuations of assets in Alzheimer’s and migraine, AstraZeneca is stepping away from neuro ...

AstraZeneca Pharmaceuticals LP should get a reprieve from the disability bias claim of an employee fired for refusing ...

Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company investigates whether a recipient’s “potentially unexplained” illness is a side effect ...

The diplomatic row that broke out last week over the supply of AstraZeneca’s vaccine to Europe appears to have cooled after the UK pharma agreed to supply an extra nine million doses.

European safety regulators have launched an investigation into the safety of a batch of the Oxford University/AstraZeneca COVID-19 vaccine, as countries including Denmark suspended its use as a ...

(Reuters) -AstraZeneca has rejoined the main U.S. drug lobby group, roughly two years after leaving it, the Pharmaceutical Research and Manufacturers of America (PhRMA) said on Tuesday. This ...

OAZisCare, digitally powered by DocquityCare, has advanced patient education and adherence for cancer care and RSV vaccines since 2024 The collaboration helps tackle Southeast Asia's healthcare needs, ...

as locked contentWangmo Kira vaccine, Oxford-AstraZeneca locked contentobserve. wons as adverse locked contentvaccine, Dzong Oxford-AstraZeneca in locked contentas Tshechu adverse it locked ...

The NHS Covid spring booster campaign is under way, but vaccines are also available privately. Three women who worked on the Oxford AstraZeneca Covid vaccine talk to the BBC about their work.

vaccines, and rare diseases, with a strong global market presence and innovative, high-margin products. Financially robust, AstraZeneca's revenue reached $54.1 billion, with a 34% increase in ...

In the latest market close, Astrazeneca (AZN) reached $64.90, with a -1.35% movement compared to the previous day. The stock's change was more than the S&P 500's daily loss of 1.57%. Elsewhere ...